Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Phenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol.

Parsons LM, Salfinger M, Clobridge A, Dormandy J, Mirabello L, Polletta VL, Sanic A, Sinyavskiy O, Larsen SC, Driscoll J, Zickas G, Taber HW.

Antimicrob Agents Chemother. 2005 Jun;49(6):2218-25.

2.

Spoligologos: a bioinformatic approach to displaying and analyzing Mycobacterium tuberculosis data.

Driscoll JR, Bifani PJ, Mathema B, McGarry MA, Zickas GM, Kreiswirth BN, Taber HW.

Emerg Infect Dis. 2002 Nov;8(11):1306-9.

3.

Estimated costs of false laboratory diagnoses of tuberculosis in three patients.

Northrup JM, Miller AC, Nardell E, Sharnprapai S, Etkind S, Driscoll J, McGarry M, Taber HW, Elvin P, Qualls NL, Braden CR.

Emerg Infect Dis. 2002 Nov;8(11):1264-70.

4.

DNA typing of a nonviable culture of Mycobacterium tuberculosis in a homeless shelter outbreak.

Driscoll JR, McGarry MA, Taber HW.

J Clin Microbiol. 1999 Jan;37(1):274-5. No abstract available.

5.

Catabolite regulation of the Bacillus subtilis ctaBCDEF gene cluster.

Liu X, Taber HW.

J Bacteriol. 1998 Dec;180(23):6154-63.

6.

Drug resistance in tuberculosis.

Parsons LM, Driscoll JR, Taber HW, Salfinger M.

Infect Dis Clin North Am. 1997 Dec;11(4):905-28. Review.

PMID:
9421707
7.

Sequence and genetic organization of a Bacillus subtilis operon encoding 2,3-dihydroxybenzoate biosynthetic enzymes.

Rowland BM, Grossman TH, Osburne MS, Taber HW.

Gene. 1996 Oct 31;178(1-2):119-23.

PMID:
8921902
9.

Transcriptional regulation of the Bacillus subtilis menp1 promoter.

Qin X, Taber HW.

J Bacteriol. 1996 Feb;178(3):705-13.

10.

Sequence organization and regulation of the Bacillus subtilis menBE operon.

Driscoll JR, Taber HW.

J Bacteriol. 1992 Aug;174(15):5063-71.

11.

The Bacillus subtilis menCD promoter is responsive to extracellular pH.

Hill KF, Mueller JP, Taber HW.

Arch Microbiol. 1990;153(4):355-9.

PMID:
2110807
12.
14.

Bacterial uptake of aminoglycoside antibiotics.

Taber HW, Mueller JP, Miller PF, Arrow AS.

Microbiol Rev. 1987 Dec;51(4):439-57. Review. No abstract available.

15.
16.
17.
18.

Involvement of menaquinone in the active accumulation of aminoglycosides by Bacillus subtilis.

Taber HW, Sugarman BJ, Halfenger GM.

J Gen Microbiol. 1981 Mar;123(1):143-9.

PMID:
6798165
19.
21.
22.
23.

Physiological effects of menaquinone deficiency in Bacillus subtilis.

Farrand SK, Taber HW.

J Bacteriol. 1973 Sep;115(3):1035-44.

24.

Pleiotropic menaquinone-deficient mutant of Bacillus subtilis.

Farrand SK, Taber HW.

J Bacteriol. 1973 Sep;115(3):1021-34.

25.

SPECTROPHOTOMETRIC ANALYZERS FOR DISC ELECTROPHORESIS: STUDIES OF YEAST CYTOCHROME C.

TABER HW, SHERMAN F.

Ann N Y Acad Sci. 1964 Dec 28;121:600-15. No abstract available.

PMID:
14240555
26.

ELECTRON TRANSPORT IN STAPHYLOCOCCI. PROPERTIES OF A PARTICLE PREPARATION FROM EXPONENTIAL PHASE STAPHYLOCOCCUS AUREUS.

TABER HW, MORRISON M.

Arch Biochem Biophys. 1964 May;105:367-79. No abstract available.

PMID:
14186744

Supplemental Content

Loading ...
Support Center